DEA & SAMHSA MAT Compliance Experts
Have a question about the latest MAT regulations or patient limits? We can help.
Just want to be sure you’re doing it right? We can help.
Want more of your providers to get waivered but they have concerns? We can help.
Concerned about a possible DEA visit to your office because of MAT? We can help.
Our teams of experts and SAC Wichern have been providing specialized DEA SAMHSA MAT compliance training for the last 15 years to frontline MAT providers and since his retirement, now provide compliance medical office reviews. SAC Wichern has lived through and experienced the full spectrum of the opioid epidemic during the last 20 years and now uses his knowledge to safeguard MAT providers so they can continue treat those suffering from OUD.
During 2019, SAC Wichern partnered with UCLA Medical School and their PCSS program in teaching a DEA MAT compliance class titled, “DEA MAT Regulations - Demystifying DEA’s Role & Implementing a Zero Risk Program.”
Our DEA focused compliance services are custom tailored to DATA-waived MAT providers and include a review of your medical policies and forms, procedures, charting, examinations, UDS’s, treatment plans, subordinate employee roles and responsibilities, recordkeeping, inventory management, drug security and identification of potential red flag areas and more.
Our specialized audit procedures and checklists number over 100 key elements and are routinely updated, due to changes in regulations, statutes, and medical guidelines. At the end of a PDC review you’ll know where you stand, your compliance risks, and we’ll show you how to lower your opioid risk to virtually zero. No one can match our 30 years of compliance expertise and knowledge when it comes to the DEA and SAMHSA MAT regulations.
Interested in learning more about what our SAMHSA MAT & OTP Compliance services can provide for you?
Kentucky MAT Nurse Provider C. M. - “Dennis came in and reviewed my MAT policies, procedures, and records for compliance. Based on his review and his counsel, I no longer fear prescribing MAT to my patients.”
Chicago MAT MD E. S. – “I used to believe that DEA was anti-MAT until SAC Wichern came in and explained DEA’s specific and very limited role in opioid treatment.”